Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q1 2023 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen. Welcome to the Atea Pharmaceuticals’ First Quarter 2023 Financial Results and Business Update Conference Call.

Related Keywords

Janet Hammond ,Jonae Barnes ,Arantxa Horga ,John Vavricka ,John Miller ,Jean Pierre Sommadossi ,Andrea Corcoran ,Maxwell Skor ,Deric Joseph ,Morgan Stanley ,Health Photo ,Public Health Emergency ,Nasdaq ,National Cancer Institute On Unsplash ,Exchange Commission ,Atea Pharmaceuticals Inc ,Jp Morgan ,World Health Organization ,Pfizer ,Corporate Communications At Atea Pharmaceuticals ,Atea Pharmaceuticals ,Call Transcript May ,Atea Pharmaceutical First Quarter ,Business Update Conference ,Senior Vice President ,Investor Relations ,Corporate Communications ,Atea Pharmaceutical ,Chief Executive Officer ,Chief Development Officer ,Chief Medical Officer ,Financial Officer ,Executive Vice President ,Chief Commercial Officer ,Forward Looking Statements ,Pierre Sommadossi ,National Cancer Institute ,Health Emergency ,Interest Yielding Checking Accounts ,Consulting Stocks ,